1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe GMP Cell Therapy Consumables Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe GMP Cell Therapy Consumables Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growth in cell and gene therapies
- 5.1.2 Rising demand for personalized medicine
- 5.1.3 Technological advancements in cell culture systems
5.2 Market Opportunities
- 5.2.1 Expansion of regenerative medicine applications
- 5.2.2 Increase in cell therapy clinical trials
- 5.2.3 Adoption of single-use consumables
5.3 Future Trends
- 5.3.1 Integration of automated systems in manufacturing
- 5.3.2 Growth in autologous cell therapies
- 5.3.3 Focus on reducing production costs
5.4 Impact of Drivers and Restraints
6. Europe GMP Cell Therapy Consumables Market Regional Analysis
6.1 Europe GMP Cell Therapy Consumables Market Overview
6.2 Europe GMP Cell Therapy Consumables Market Revenue 2020-2028 (US$ Million)
6.3 Europe GMP Cell Therapy Consumables Market Forecast Analysis
7. Europe GMP Cell Therapy Consumables Market Analysis – by Product
7.1 Kits
- 7.1.1 Overview
- 7.1.2 Kits: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents/Molecular Biology Reagents
- 7.2.1 Overview
- 7.2.2 Reagents/Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Growth Factors/Cytokines
- 7.3.1 Overview
- 7.3.2 Growth Factors/Cytokines: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Interleukins
- 7.4.1 Overview
- 7.4.2 Interleukins: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe GMP Cell Therapy Consumables Market Analysis – by Cell Therapy
8.1 NK Cell Therapy
- 8.1.1 Overview
- 8.1.2 NK Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Stem Cell Therapy
- 8.2.1 Overview
- 8.2.2 Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
8.3 T-Cell Therapy
- 8.3.1 Overview
- 8.3.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe GMP Cell Therapy Consumables Market Analysis – by Process
9.1 Cell Collection and Characterization/Sorting and Separation
- 9.1.1 Overview
- 9.1.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Cell Culture and Expansion/Preparation
- 9.2.1 Overview
- 9.2.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Cryopreservation
- 9.3.1 Overview
- 9.3.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cell Processing and Formulation
- 9.4.1 Overview
- 9.4.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cell Isolation and Activation
- 9.5.1 Overview
- 9.5.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Cell Distribution/Handling
- 9.6.1 Overview
- 9.6.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Process Monitoring
- 9.7.1 Overview
- 9.7.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Control/Readministration/Quality Assurance
- 9.8.1 Overview
- 9.8.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe GMP Cell Therapy Consumables Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe GMP Cell Therapy Consumables Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 Europe GMP Cell Therapy Consumables Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 10.1.1.1.2 UK: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 10.1.1.1.3 UK: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 10.1.1.2 Germany:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 10.1.1.2.2 Germany: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 10.1.1.2.3 Germany: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 10.1.1.3 France:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 10.1.1.3.2 France: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 10.1.1.3.3 France: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 10.1.1.4 Russia:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 10.1.1.4.2 Russia: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 10.1.1.4.3 Russia: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 10.1.1.5 Italy:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 10.1.1.5.2 Italy: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 10.1.1.5.3 Italy: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 10.1.1.6 Rest of Europe:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 10.1.1.6.2 Rest of Europe: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 10.1.1.6.3 Rest of Europe: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe GMP Cell Therapy Consumables Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bio-Techne Corp
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BPS Bioscience Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Corning Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 FUJIFILM Irvine Scientific Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Global Life Sciences Solutions USA LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Lonza Group AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck KGaA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Miltenyi Biotec BV & Co KG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sartorius AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe GMP Cell Therapy Consumables Market
